Functional Electrical Stimulation Market
Number of pages: 100 | Report Format: PDF | Published date: March 01, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market Size Value in 2021 |
US$ 621.3 million |
|
Revenue Forecast in 2030 |
US$ 876.7 million |
|
CAGR |
3.90% |
|
Base Year for Estimation |
2021 |
|
Forecast Period |
2022-2030 |
|
Historical Year |
2020 |
|
Segments Covered |
Product Type, Indication, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global market was valued at US$ 621.3 million in 2021 and is expected to register a revenue CAGR of 3.90% to reach US$ 876.7 million by 2030.
Functional Electrical Stimulation Market Fundamentals
Functional Electrical Stimulation (FES) is a treatment technique used by neurological physiotherapists to increase muscular strength and everyday functioning capacity following a neurological injury. The purpose of FES is to have functional muscle control compromised due to impairments. The technology was introduced in the sixties when FES devices were used as assistive devices. Since then, FES has evolved as a beneficial intervention in treating conditions, such as stroke or spinal cord injuries (SCIs). Fundamental parts of FES include an electrical stimulator, electrodes that provide stimulation, sensors for the user or automatic control of the stimulation, and occasionally, an orthosis that adds extra support for the patient to carry out the required movement.
The devices offer many benefits, such as reducing the effort needed to walk, improving balance, muscle strength, and body posture, and reducing the chance of tripping. Additional advantages of FES include improving muscle mass, decreasing venous pooling, increasing cardiac output and stroke volume, and improving cardiovascular health, especially for paralyzed patients, including those who have had SCI.
[678575]
Functional Electrical Stimulation Market Dynamics
The increasing prevalence of SCIs is the key factor fueling the global functional electrical stimulation market revenue growth. Over the past 30 years, SCIs have become more common. Men and older people are more severely impacted than females and younger people. The recent data published by the National SCI Statistical Data states that in 2021 population of people suffering from SCIs in the United States was estimated to be about 333 million. The recent estimate of the annual incidence of traumatic SCI in 2021 is approximately 54 cases per one million people in the United States, which equals about 18,000 new SCI cases yearly.
The introduction of innovative functional stimulation devices in the market is expected to support the market revenue growth during the forecast period. For instance, in 2019, MOTIONrehab launched new FES services with Fesia Walk. The organization partnered with Ectronto to introduce a new generation of FES gait rehabilitation systems. This advanced system is beneficial in neurological conditions, such as stroke, multiple sclerosis, incomplete SCI, cerebral palsy, and traumatic brain injury. Additionally, this technology is likely to undergo significant alterations to improve both its efficacy and general acceptance due to the anticipated increase in the aging population suffering from neurological conditions.
The presence of favorable reimbursement policies also increases the revenue growth of the global functional electrical stimulation market. Government bodies and leading market players are offering reimbursement for FES devices. In the United States, Medicare was expected to evaluate FES coverage for SCI (SCI) patients who have completed a three-month training program that included at least 32 physical therapy sessions with the device. The CMS NCD 160.12 states that SCI patients with ICD-10 codes G04 would be covered for FES to improve walking.
However, the high cost of products and stringent regulations are the most prominent restraints in the global functional electrical stimulation market.
Functional Electrical Stimulation Market Ecosystem
The global functional electrical stimulation market has been analyzed from four perspectives: product type, indication, end user, and region.
Functional Electrical Stimulation Market by Product Type
[7856456]
Based on the product type, the global functional electrical stimulation market has been segmented into wired and wireless.
The wired segment dominates the global functional electrical stimulation market with the largest revenue share due to its traditional usage and high demand in low-income countries. The segment is expected to grow at higher revenue CAGR during the forecast period. Unlike standard wired electrical stimulation, wireless and remote light stimulation enable less invasive and longer-lasting interaction, holding considerable potential for the treatment of nerve injuries and neurodegenerative disorders, as well as human-computer interaction. Moreover, the increasing preference of market players to introduce wireless systems in the market is also attributed to the high demand for wireless FES devices. This is due to advantages offered by wireless systems in treating conditions, such as improved portability, reduced risk of infection due to fewer wires and electrodes, and improved comfort for patients who may not be accustomed to wires or electrodes on the skin. The segment is also experiencing growth as many market players are launching new and advanced products. For instance, Walnut Medical is the first company to commercialize FES system that can be used for upper limb rehabilitation in dynamic mode with a wireless EMG sensor and lower limb foot drop therapy with a wireless/wired heel sensor. Patients can utilize the Walkex FES and select an appropriate one for their upper or lower leg.
Functional Electrical Stimulation Market by Application
Based on the application, the global functional electrical stimulation market has been segmented into neurological conditions, pain management, musculoskeletal disorders, and others.
The neurological conditions segment accounted for the majority of the global functional electrical stimulation market revenue share in 2021. FES has been used to treat a range of neurological disorders, including SCI, cerebral palsy, multiple sclerosis, and stroke. It can help improve mobility, reduce pain, and improve muscle strength and coordination. FES system can also help improve balance and coordination. The major advantage of FES is its ability to restore movement in patients with limited mobility and paralysis. FES can also be used to help improve muscle strength and coordination and to reduce pain. In addition, FES can be combined with other therapies, such as physical therapy, to maximize its effectiveness.
Functional Electrical Stimulation Market by End User
Based on the end user, the global functional electrical stimulation market has been segmented into hospitals, ambulatory surgical centers, and clinics.
Due to increased patient admissions and frequent visits, the hospitals segment produces the highest revenue. The World Health Organization states that more than 1 billion people worldwide exhibit neurological diseases that need intensive medical attention, increasing the frequency of hospital visits. Furthermore, highly improved products for the treatment of neurological diseases are available in hospitals.
Functional Electrical Stimulation Market by Region
Based on the region, the global functional electrical stimulation market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America leads the global market due to the high prevalence of neurological disorders and the large concentration of market players in the region. According to the University of Texas Medical Branch, stroke is the sixth most common cause of mortality and a major contributor to substantial long-term disability in the United States. More than half of stroke survivors aged 65 and older experience reduced mobility. Furthermore, the region’s growth is also attributed to the availability of well-established healthcare infrastructure and favorable reimbursement policies in the United States.
Europe accounts for the second-largest market revenue share. One of the primary reasons driving the market in the region is the widespread adoption and awareness regarding treatments. This can be ascribed to the presence of top players increasing the easy accessibility to the products.
Asia Pacific is one of the world’s fastest-growing regions. The region’s high per capita income and advancements in healthcare settings are anticipated to boost the functional electrical stimulation market. Attractive reimbursement policies and awareness of this therapy and its advantages are also anticipated to fuel revenue growth in the functional electrical stimulation market revenue during the forecast period.
Functional Electrical Stimulation Market Competitive Landscape
The prominent players in the global functional electrical stimulation market include:
Functional Electrical Stimulation Market Strategic Developments
The high adoption of advanced rehabilitation systems in the treatment of musculoskeletal disorders is the most prominent trend in the global functional electrical stimulation market.
Some prominent players in the global functional electrical stimulation market include HASOMED GmbH, Bioventus, LLC, Otto Bock SE & Co. KGaA, and Hobbs Rehabilitation.
The wireless segment is anticipated to grow at a rapid pace during the forecast period.
The market in Asia Pacific is expected to mark the highest revenue growth during the forecast period.
The high cost of products and stringent regulations are the major restraints in the global functional electrical stimulation market.
*Insights on financial performance are subject to the availability of information in the public domain